| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 156,641 | 112,224 | 87,925 | 98,296 | | Cost of Revenue | 81,047 | 59,181 | 45,844 | 49,973 | | | Gross Profit | 75,594 | 53,043 | 42,081 | 48,323 | | | Operating Expenses | | Research Development | 32,619 | 30,480 | 29,045 | 30,705 | | Selling General and Administrative | 23,050 | 21,177 | 19,346 | 19,013 | | Non Recurring | 977 |
-
|
-
|
-
| | Others | 2,580 | 2,885 | 2,885 | 2,885 | | | | Total Operating Expenses | 59,226 |
-
|
-
|
-
| | | | Operating Income or Loss | 16,368 | (1,499) | (9,195) | (4,280) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 477 | 1,533 | 564 | (2,488) | | Earnings Before Interest And Taxes | 16,845 | 34 | (8,631) | (6,768) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 16,845 | 34 | (8,631) | (6,768) | | Income Tax Expense | (21,731) | 284 | (1,079) | (2,010) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 38,576 | (250) | (7,552) | (4,758) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 38,576 | (250) | (7,552) | (4,758) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $38,576 | ($250) | ($7,552) | ($4,758) |
|
1.52% Nasdaq 0.00%
Income Statement
